Roswell Park Cancer Institute: Sarcoma trials

The registry lists 10 Sarcoma studies with Roswell Park Cancer Institute as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 5Phase 2 1Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility StudyRecruitingNCT07402577
• Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal MetastasesRecruitingNCT03965234Phase 1/2
• High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00536601Not applicableResults posted
• Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue SarcomaWithdrawnNCT06670976Phase 1
• CBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaTerminatedNCT03727789Phase 1
• Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy VolunteersTerminatedNCT03630601Not applicable
• Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
• Cisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisCompletedNCT01014598Phase 1
• Doxorubicin in Treating Patients With AIDS-Related Kaposi's SarcomaCompletedNCT00002985Phase 3
• Altretamine and Etoposide in Treating Patients With HIV-Related CancerCompletedNCT00002936Phase 1